These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 13340565)

  • 1. The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy.
    COSGRIFF SW
    Ann Intern Med; 1956 Jul; 45(1):14-22. PubMed ID: 13340565
    [No Abstract]   [Full Text] [Related]  

  • 2. Mephyton (emulsified vitamin K1) in the treatment of excessive therapeutic hypoprothrombinemia.
    STRAGNELL R; WARE AG
    Med Clin North Am; 1954 Mar; 11():413-7. PubMed ID: 13153516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
    SOULIER JP; SOULLARD J
    Sang; 1952; 23(8):709-14. PubMed ID: 13004931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of water-soluble vitamin K (menadione sodium bisulfite) and vitamin K1 on hypoprothrombinemia during anticoagulant therapy].
    STURUP H
    Ugeskr Laeger; 1954 Feb; 116(8):294-7. PubMed ID: 13146907
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of intravenous injection of emulsified vitamin K1 on the hypoprothrombinemia induced by tromexan.
    VAN BUSKIRK WC
    N Engl J Med; 1953 Jan; 248(2):57-8. PubMed ID: 13002683
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothrombinemia.
    GUTTAS CG; MOLONEY WC; SISE HS
    Blood; 1953 Mar; 8(3):276-81. PubMed ID: 13032197
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.
    SHOSHKES M; PERELMAN AJ
    J Am Med Assoc; 1956 Jul; 161(12):1145-7. PubMed ID: 13331775
    [No Abstract]   [Full Text] [Related]  

  • 8. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
    REHBEIN A; JARETZKI A; HABIF DV
    Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral phytonadione in neonatal hypoprothrombinemia.
    SHOSHKES M; EPPLEBAUM A; WILNER M
    J Pediatr; 1959 Jul; 55(1):80-4. PubMed ID: 13665488
    [No Abstract]   [Full Text] [Related]  

  • 10. Orally administered phytonadione in bishydroxycoumarin-induced hypoprothrombinemia.
    SHOSHKES M; ROBINS B; YELIN G
    J Am Med Assoc; 1957 Sep; 165(4):330-3. PubMed ID: 13462790
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoprothrombinemia following the use of propylthiouracil: case report.
    MIRRER GP
    Ann Intern Med; 1955 Nov; 43(5):1124-7. PubMed ID: 13269004
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effects of synthetic vitamin K1 in some hypoprothrombinemic states].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):89-101. PubMed ID: 13290058
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.
    WATKIN DM; VAN ITALLIE TB; LOGAN WB; GEYER RP; DAVIDSON CS; STARE FJ
    J Lab Clin Med; 1951 Feb; 37(2):269-71. PubMed ID: 14814353
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical comparison of vitamin K1 and water-soluble vitamin K.
    GAMBLE JR; DENNIS EW; COON WW; HODGSON P; WILLS PW; MACRIS JA; DUFF IF
    AMA Arch Intern Med; 1955 Jan; 95(1):52-8. PubMed ID: 13217503
    [No Abstract]   [Full Text] [Related]  

  • 15. The response of hypoprothrombinemia in cirrhosis to vitamin K1 and K3.
    WEINER M; FARHANGI M
    Am J Med Sci; 1961 Aug; 242():207-10. PubMed ID: 13783903
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously.
    SHOSHKES M; GEYER RP; YEE GS; STARE FJ
    J Lab Clin Med; 1950 Oct; 36(4):531-6. PubMed ID: 14779068
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new study on the therapeutic action of vitamin K1 on hypoprothrombinemia in the premature infant].
    VERGER P; LACHAUD
    Nourrisson; 1959; 47():221-6. PubMed ID: 13855226
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of water-soluble derivatives of vitamin K1 in counteracting drug-induced hypoprothrombinemia.
    MUSHETT CW; KELLEY KL; HIRSCHMANN R
    Blood; 1959 Jan; 14(1):37-49. PubMed ID: 13607577
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of hypoprothrombinemia vitamin K1 emulsion (Mephyton).
    REHBEIN A; JARETZKI A; HABIF DV
    Merck Rep; 1953 Apr; 62(2):20-2. PubMed ID: 13071665
    [No Abstract]   [Full Text] [Related]  

  • 20. ORAL USE of phytonadione.
    J Am Med Assoc; 1957 Jan; 163(1):39. PubMed ID: 13376342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.